Trial Profile

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Moderate to Severe Hidradenitis Suppurativa

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 19 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Izokibep (Primary)
Indications Hidradenitis suppurativa
Focus Registrational; Therapeutic Use
Sponsors ACELYRIN

Most Recent Events

18 May 2024 This trial has been completed in Germany, According to European Clinical Trials Database record.
09 May 2024 According to an ACELYRIN Media Release, top line data for both trials now expected by end of fourth quarter of 2024.
22 Mar 2024 This trial has been completed in Hungary (End date: 2024-02-21) According to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com